EMEND is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Aprepitant.
| Product ID | 0006-0462_137e0347-9e23-4cc0-a44a-8c88d8983e17 |
| NDC | 0006-0462 |
| Product Type | Human Prescription Drug |
| Proprietary Name | EMEND |
| Generic Name | Aprepitant |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2003-03-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021549 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | APREPITANT |
| Active Ingredient Strength | 125 mg/1 |
| Pharm Classes | Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2003-03-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021549 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2003-03-26 |
| Marketing Category | NDA |
| Application Number | NDA021549 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2003-03-26 |
| Marketing End Date | 2010-07-14 |
| Marketing Category | NDA |
| Application Number | NDA021549 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2003-03-26 |
| Marketing End Date | 2020-05-31 |
| Ingredient | Strength |
|---|---|
| APREPITANT | 125 mg/1 |
| SPL SET ID: | 696f9e80-9cae-403b-de9e-078343ce4713 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-0461 | EMEND | aprepitant |
| 0006-0462 | EMEND | aprepitant |
| 0006-0464 | EMEND | aprepitant |
| 0006-3061 | EMEND | FOSAPREPITANT DIMEGLUMINE |
| 0006-3066 | EMEND | aprepitant |
| 0006-3862 | EMEND | aprepitant |
| 0006-3941 | EMEND | EMEND |
| 42254-160 | EMEND | EMEND |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EMEND 98452421 not registered Live/Pending |
EMEND, LLC 2024-03-15 |
![]() EMEND 90879357 not registered Live/Pending |
EMEND, LLC 2021-08-12 |
![]() EMEND 90879262 not registered Live/Pending |
EMEND, LLC 2021-08-12 |
![]() EMEND 90816895 not registered Live/Pending |
EMEND, LLC 2021-07-08 |
![]() EMEND 88511573 not registered Live/Pending |
Lonza Ltd. 2019-07-12 |
![]() EMEND 78449789 3154890 Live/Registered |
Medion Corporation 2004-07-13 |
![]() EMEND 76254977 2725335 Dead/Cancelled |
Merck & Co., Inc. 2001-05-10 |
![]() EMEND 75292656 2417822 Live/Registered |
MERCK & CO., Inc. 1997-05-15 |
![]() EMEND 74619649 2032756 Dead/Cancelled |
CLINITEX MEDICAL CORPORATION 1995-01-10 |